MB Act for bio Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
11,385 |
- |
738 |
703 |
- |
94.91 |
6.17 |
-1,215 |
4,634 |
0 |
3,419 |
2023 |
---|
24,021 |
- |
3,870 |
3,767 |
- |
94.14 |
15.68 |
2,553 |
712 |
0 |
3,265 |
2024 |
---|
24,688 |
- |
4,664 |
4,370 |
- |
94.90 |
17.70 |
6,922 |
344 |
0 |
7,266 |
Register and
explore Okredo data2024 |
---|
24,688 |
- |
4,664 |
4,370 |
- |
94.90 |
17.70 |
6,922 |
344 |
0 |
7,266 |
Register and
explore Okredo data2024
Turnover (€)
24,688 €3 % *
Sales per employee (€)
-Profit before tax (€)
4,664 €21 % *
Net Profit (€)
4,370 €16 % *
Profit per employee (€)
-Total profitability (%)
94.90 %0.81 % *
Net profitability (%)
17.70 %12.88 % *
Equity (€)
6,922 €171 % *
Amounts Payable And Liabilities (€)
344 €-52 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
7,266 €123 % *